Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2005, Aphelion Capital is a healthcare venture capital firm based in the United States. The firm specializes in early and mid-stage investments in medical device and digital health companies. Aphelion Capital aims to improve patient outcomes while maintaining or lowering costs to the healthcare system.
Aphelion Capital invests in medical technologies and services that enhance healthcare delivery. The firm targets early and mid-stage companies dedicated to improving clinical outcomes and emphasizes financial discipline in their operations. Investment stages range from pre-seed to Series C, with a focus on innovative approaches to healthcare.
Notable companies in Aphelion Capital's portfolio include Hill-Rom, Merit Medical, GHX, Sonova, Stryker, Conmed, and Teleflex, showcasing a mix of active companies and those that have gone public.
To pitch Aphelion Capital, submit your proposal through their form at aphelioncapital.net or email your deck to venturedeals@aphelioncap.com.
Yes, Aphelion Capital often leads investment rounds, particularly in early-stage companies where they can provide significant support and resources.
The firm is open to follow-on investments, especially in companies that demonstrate strong growth and alignment with their investment thesis.
Specific fund size details are not disclosed, but the firm has a history of investing in multiple rounds across various healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.